Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

768962

	registered interest
	date	11/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes and Hypertension: Pharmacy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what plans his Department has to evolve Medicines Use Reviews to enable community pharmacists to better support people with long-term conditions such as diabetes and high blood pressure.
	tabling member constituency	Mid Derbyshire
	tabling member printed	Pauline Latham
	uin	107290
	answer	answer is ministerial correction date of answer 19/10/2017 answer text <p>The Department is committed to supporting people with long term conditions manage their illness and take their medication correctly. In line with this ambition, eligibility for Medicine Use Reviews was amended from April 2015, to better target these services at patients who would derive the most benefit from it. This change required 70% of Medicine Use Reviews to be held with people within key target groups which included people with conditions such as diabetes or high blood pressure.</p><p> </p><p>The Department continues to develop and monitor the evidence base and effectiveness of all Advanced Services provided by community pharmacists to improve patient outcomes and make the best use of National Health Service resources. It will continue to do so and develop plans accordingly.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/10/2017 16:24:21 answering member 4067 label Biography information for Steve Brine
	tabling member	4025 label Biography information for Mrs Pauline Latham

767780

	registered interest
	date	14/09/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pharmacy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what plans his Department has to expand the role of pharmacies.
	tabling member constituency	Mid Derbyshire
	tabling member printed	Pauline Latham
	uin	901028
	answer	answer is ministerial correction date of answer 10/10/2017 answer text <p>Community pharmacies provide vital front line health services. We want them to be even more integrated with the wider health system and used more often by the public for their health needs. We are taking action to make that happen; for example, we have re-commissioned the delivery of flu vaccinations and will be re-running the ‘stay well this winter campaign’ this year.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 10/10/2017 15:51:02 answering member 4067 label Biography information for Steve Brine
	tabling member	4025 label Biography information for Mrs Pauline Latham

754107

	registered interest
	date	19/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer Drugs Fund
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when will companies following a recommendation for use from the Cancer Drugs Fund be able to access Cancer Drugs Fund funding for a drug which they have previously been making available to the NHS free of charge by means of the Early Access to Medicines Scheme.
	tabling member constituency	Mid Derbyshire
	tabling member printed	Pauline Latham
	uin	6302
	answer	answer is ministerial correction date of answer 06/09/2017 answer text <p>Under the new arrangements for the appraisal and funding of cancer drugs introduced in July 2016, the National Institute for Health and Care Excellence (NICE) aims to publish draft recommendations on the use of all cancer drugs before licensing. Where NICE’s draft guidance recommends use of the drug for routine commissioning or for use through the Cancer Drugs Fund, NHS England will make Cancer Drugs Fund funding available for its use in National Health Service patients in line with NICE’s recommendations from the point of licensing. There should therefore be no gap in the availability of cancer drugs recommended by NICE that had previously been made available before licensing under the Early Access to Medicines Scheme.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/09/2017 12:57:24 answering member 4067 label Biography information for Steve Brine
	tabling member	4025 label Biography information for Mrs Pauline Latham

751368

	registered interest
	date	12/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Medical Treatments: Innovation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what funding is available for treatments which have been made available under the Early Access to Medicines Scheme after marketing authorisation but before the publication of NICE guidance.
	tabling member constituency	Mid Derbyshire
	tabling member printed	Pauline Latham
	uin	4699
	answer	answer is ministerial correction date of answer 20/07/2017 answer text <p>The Early Access to Medicines Schemes is a voluntary scheme. Companies are not paid for the medicines they supply into the scheme. However, the Government has recently announced new funding as part of a of a wider package of up to £86 million aimed at addressing barriers to uptake of innovation that were recommended in the Accelerated Access Review. Small to Medium Enterprises with products that meet the requirements for the Early Access to Medicines Scheme will be able to access this funding opportunity. Further announcements will be made on how small businesses can apply for this support. More information can be found at this link:</p><p> </p><p><a href="https://www.gov.uk/government/news/86-million-funding-announced-for-new-medicine-and-technology" target="_blank">https://www.gov.uk/government/news/86-million-funding-announced-for-new-medicine-and-technology</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 4700 question first answered 20/07/2017 15:14:36 answering member 4067 label Biography information for Steve Brine
	tabling member	4025 label Biography information for Mrs Pauline Latham

751369

	registered interest
	date	12/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Medical Treatments: Innovation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what plans he has to transfer the funding of medicines under the Early Access to Medicines Scheme from pharmaceutical companies to the NHS.
	tabling member constituency	Mid Derbyshire
	tabling member printed	Pauline Latham
	uin	4700
	answer	answer is ministerial correction date of answer 20/07/2017 answer text <p>The Early Access to Medicines Schemes is a voluntary scheme. Companies are not paid for the medicines they supply into the scheme. However, the Government has recently announced new funding as part of a of a wider package of up to £86 million aimed at addressing barriers to uptake of innovation that were recommended in the Accelerated Access Review. Small to Medium Enterprises with products that meet the requirements for the Early Access to Medicines Scheme will be able to access this funding opportunity. Further announcements will be made on how small businesses can apply for this support. More information can be found at this link:</p><p> </p><p><a href="https://www.gov.uk/government/news/86-million-funding-announced-for-new-medicine-and-technology" target="_blank">https://www.gov.uk/government/news/86-million-funding-announced-for-new-medicine-and-technology</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 4699 question first answered 20/07/2017 15:14:36 answering member 4067 label Biography information for Steve Brine
	tabling member	4025 label Biography information for Mrs Pauline Latham